Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Tennessee
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Tennessee
3 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Tennessee.
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- University Neurology, Knoxville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07091630A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- GC2402 Study Site 111, Cordova
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Cinical Study Site, Nashville
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.